These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 18827902)

  • 1. Relaxin as a natural agent for vascular health.
    Bani D
    Vasc Health Risk Manag; 2008; 4(3):515-24. PubMed ID: 18827902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise, vascular wall and cardiovascular diseases: an update (Part 1).
    Leung FP; Yung LM; Laher I; Yao X; Chen ZY; Huang Y
    Sports Med; 2008; 38(12):1009-24. PubMed ID: 19026018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection from cigarette smoke-induced vascular injury by recombinant human relaxin-2 (serelaxin).
    Pini A; Boccalini G; Baccari MC; Becatti M; Garella R; Fiorillo C; Calosi L; Bani D; Nistri S
    J Cell Mol Med; 2016 May; 20(5):891-902. PubMed ID: 26915460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells.
    Failli P; Nistri S; Quattrone S; Mazzetti L; Bigazzi M; Sacchi TB; Bani D
    FASEB J; 2002 Feb; 16(2):252-4. PubMed ID: 11744624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxin-induced increased coronary flow through stimulation of nitric oxide production.
    Bani-Sacchi T; Bigazzi M; Bani D; Mannaioni PF; Masini E
    Br J Pharmacol; 1995 Sep; 116(1):1589-94. PubMed ID: 8564223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxin inhibits lipopolysaccharide-induced adhesion of neutrophils to coronary endothelial cells by a nitric oxide-mediated mechanism.
    Nistri S; Chiappini L; Sassoli C; Bani D
    FASEB J; 2003 Nov; 17(14):2109-11. PubMed ID: 14500542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of endothelial nitric oxide in the regulation of the vasomotor system].
    Michel JB
    Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention.
    Conrad KP
    Hum Reprod Update; 2016 Sep; 22(5):647-64. PubMed ID: 27385360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxin is a potent renal vasodilator in conscious rats.
    Danielson LA; Sherwood OD; Conrad KP
    J Clin Invest; 1999 Feb; 103(4):525-33. PubMed ID: 10021461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of estrogen on endothelial function and angiogenesis.
    Rubanyi GM; Johns A; Kauser K
    Vascul Pharmacol; 2002 Feb; 38(2):89-98. PubMed ID: 12379955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia.
    Conrad KP
    Semin Nephrol; 2011 Jan; 31(1):15-32. PubMed ID: 21266262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vascular actions of relaxin.
    Jeyabalan A; Shroff SG; Novak J; Conrad KP
    Adv Exp Med Biol; 2007; 612():65-87. PubMed ID: 18161482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxin as a cardiovascular drug: a promise kept.
    Bani D; Bigazzi M
    Curr Drug Saf; 2011 Nov; 6(5):324-8. PubMed ID: 22424540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?
    Conrad KP; Davison JM
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1121-35. PubMed ID: 24647709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From pregnancy to cardiovascular disease: Lessons from relaxin-deficient animals to understand relaxin actions in the vascular system.
    Jelinic M; Marshall SA; Leo CH; Parry LJ; Tare M
    Microcirculation; 2019 Feb; 26(2):e12464. PubMed ID: 29876993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of relaxin in renal and cardiovascular function.
    Conrad KP; Novak J
    Am J Physiol Regul Integr Comp Physiol; 2004 Aug; 287(2):R250-61. PubMed ID: 15271674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relaxin potentiates the expression of inducible nitric oxide synthase by endothelial cells from human umbilical vein in in vitro culture.
    Quattrone S; Chiappini L; Scapagnini G; Bigazzi B; Bani D
    Mol Hum Reprod; 2004 May; 10(5):325-30. PubMed ID: 15026539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxin as a cardiovascular hormone: physiology, pathophysiology and therapeutic promises.
    Nistri S; Bigazzi M; Bani D
    Cardiovasc Hematol Agents Med Chem; 2007 Apr; 5(2):101-8. PubMed ID: 17430134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological or pathological--a role for relaxin in the cardiovascular system?
    Samuel CS; Parry LJ; Summers RJ
    Curr Opin Pharmacol; 2003 Apr; 3(2):152-8. PubMed ID: 12681237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide and angiogenesis in cardiovascular disease.
    Murohara T; Asahara T
    Antioxid Redox Signal; 2002 Oct; 4(5):825-31. PubMed ID: 12470511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.